Therapeutic Drug Monitoring (TDM) of Biologics with Theradiag

TDM in Chronic Inflammatory Diseases (CID)

Biologic therapies, and notably Monoclonal antibodies (mAbs) and Fusion Proteins (FP), have revolutionised the management of CID, such as Inflammatory Bowel Disease, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriasis and Psoriatic Arthritis that affect millions of people worldwide.

Read more
Top